Sessions are scheduled in local time (CEST)

Displaying One Session

View
Hamburg Hall Industry Satellite Symposium

Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach (ID 8)

Date
Sat, 13.05.2023
Time
12:30 - 13:30
Room
Hamburg Hall
Chairs
  • Peter A. Fasching (Erlangen, Germany)
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach

Welcome and introduction (ID 186)

Lecture Time
12:30 - 13:30
Session Name
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach
Room
Hamburg Hall
Date
Sat, 13.05.2023
Time
12:30 - 13:30
Speakers
  • Peter A. Fasching (Erlangen, Germany)
Authors
  • Peter A. Fasching (Erlangen, Germany)
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach

Patient case 1: The importance of accurately identifying HER2 status (ID 187)

Lecture Time
13:30 - 13:30
Session Name
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach
Room
Hamburg Hall
Date
Sat, 13.05.2023
Time
12:30 - 13:30
Speakers
  • Magali Lacroix-Triki (Villejuif, France)
Authors
  • Magali Lacroix-Triki (Villejuif, France)
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach

Patient case 2: Treatment options for patients with HER2-low expressing tumours (ID 188)

Lecture Time
13:30 - 13:30
Session Name
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach
Room
Hamburg Hall
Date
Sat, 13.05.2023
Time
12:30 - 13:30
Speakers
  • Peter A. Fasching (Erlangen, Germany)
Authors
  • Peter A. Fasching (Erlangen, Germany)
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach

Patient case 3: Optimising adverse events management in HER2+ metastatic breast cancer (ID 189)

Lecture Time
13:30 - 13:30
Session Name
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach
Room
Hamburg Hall
Date
Sat, 13.05.2023
Time
12:30 - 13:30
Speakers
  • Cristina Saura Manich (Barcelona, Spain)
Authors
  • Cristina Saura Manich (Barcelona, Spain)
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach

Panel discussion and Q&A (ID 190)

Lecture Time
13:30 - 13:45
Session Name
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach
Room
Hamburg Hall
Date
Sat, 13.05.2023
Time
12:30 - 13:30
Speakers
  • To be Announced (Barcelona, Spain)
Authors
  • To be Announced (Barcelona, Spain)
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach

Closing remarks (ID 191)

Lecture Time
13:45 - 13:50
Session Name
Daiichi Sankyo | AstraZeneca - HER2 treat: Discussing challenging breast cancer cases – An interdisciplinary and interactive approach
Room
Hamburg Hall
Date
Sat, 13.05.2023
Time
12:30 - 13:30
Speakers
  • Peter A. Fasching (Erlangen, Germany)
Authors
  • Peter A. Fasching (Erlangen, Germany)